GlassScriptPhysician profile
Nicholas J Fitzsimons
NPI 1275708125
$8,818.47
in general payments reported to CMS, 2019-2025
51 companies · $1,781 in 2025
The $1,781 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $629 · 2021: $1,201 · 2022: $1,334 · 2023: $1,905 · 2024: $1,456 · 2025: $1,781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,142.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $703.49 | 2020-2024 | Xyosted, Nocdurna, Tlando |
| Astellas Pharma US INC | $659.06 | 2019-2025 | Xtandi |
| Boston Scientific Corporation | $601.89 | 2019-2025 | General - Erectile Dysfunction, Lithovue, Axonics |
| Janssen Biotech, INC. | $473.32 | 2020-2025 | Erleada |
| Urogen Pharma, INC. | $452.79 | 2021-2025 | Jelmyto |
| Sumitomo Pharma America, INC. | $434.67 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $412.23 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $390.36 | 2023-2025 | Provenge |
| Pfizer INC. | $300.54 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $289.48 | 2023-2025 | |
| Zyla Life Sciences, INC. | $242.06 | 2019-2020 | |
| Laborie Medical Technologies Corp. | $219.04 | 2022-2023 | |
| Myovant Sciences INC. | $213.28 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $210.37 | 2019-2023 | Xiaflex, Aveed |
| Coloplast Corp | $196.36 | 2019-2025 | Speedicath |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $182.86 | 2019-2025 | Posluma |
| Procept Biorobotics Corporation | $176.54 | 2022-2024 | Aquabeam System |
| Axonics, INC. | $175.48 | 2021-2023 | Axonics |
| Myriad Genetic Laboratories, INC. | $168.48 | 2021-2024 | Prolaris |
| Endo USA, INC. | $160.71 | 2024-2025 | Aveed, Xiaflex |
| Immunitybio, INC. | $156.75 | 2025 | |
| Medtronic, INC. | $141.04 | 2023 | Interstim |
| Innovation Technologies INC | $136.36 | 2025 | Irrisept |
| Clarus Therapeutics INC. | $128.28 | 2021 | |
| Calyxo, INC. | $125.52 | 2025 | Cvac Aspiration System |
| Merck Sharp & Dohme LLC | $121.79 | 2022-2025 | Keytruda, Welireg |
| Ferring Pharmaceuticals INC. | $114.20 | 2024-2025 | Adstiladrin |
| Travere Therapeutics, INC. | $113.61 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $104.28 | 2025 | |
| Sun Pharmaceutical Industries INC. | $77.00 | 2025 | |
| Halozyme INC | $76.92 | 2023 | |
| Ethicon US, LLC | $76.53 | 2022-2024 | Vistaseal |
| Accord Healthcare, INC. | $73.43 | 2023 | |
| Smith+Nephew, INC. | $72.27 | 2021-2024 | Stravix |
| Teleflex LLC | $70.62 | 2021-2024 | Urolift |
| Kerecis Limited | $65.83 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Urovant Sciences INC | $61.65 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $60.86 | 2024 | |
| Aytu Biopharma, INC. | $51.06 | 2019-2020 | |
| Allergan, INC. | $47.41 | 2021 | |
| Bioprotect Medical, INC. | $39.88 | 2024 | Bioprotect Balloon Implant System |
| Tolmar Pharmaceuticals, INC. | $37.69 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $36.42 | 2023-2024 | Pylarify |
| Tolmar, INC. | $31.16 | 2025 | Jatenzo, Eligard |
| Mission Pharmacal Company | $28.35 | 2019 | |
| Acerus Pharmaceuticals Corporation | $25.73 | 2020-2021 | |
| Olympus America INC. | $20.12 | 2023 | Itind System |
| Rochester Medical Corporation | $16.76 | 2020 | |
| Avadel Specialty Pharmaceuticals, LLC | $15.93 | 2019 | |
| Photocure INC | $15.63 | 2023 | Cysview |
| Verity Pharmaceuticals INC. | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Fitzsimons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.